Recherche
-
Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis.
(Biomedicines. vol. 10, n° 12, 2022-12-07)Article de revueLibre accès -
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting
(Clinical Pharmacology and Therapeutics. vol. 103, n° 6, pp. 1038-1046, 2018-06)Article de revue -
Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study
(The American Journal of Medicine. vol. 132, n° 6, pp. 740-748 e7, 2019)Article de revue -
The Reply : Impact of Average Daily and Cumulative Dose of Statins on Mortality Risk Among Healthy Elderly
(The American Journal of Medicine. vol. 132, n° 7, pp. e622, 2019)Article de revue -
How Long Do Implanted Triclosan Sutures Inhibit Staphylococcus aureus in Surgical Conditions? A Pharmacological Model
(Pharmaceutics. vol. 14, n° 3, 2022-02-28)Article de revueLibre accès -
Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
(Clinical Colorectal Cancer. vol. 17, n° 2, pp. 129-139, 2018-06)Article de revue -
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study
(British Journal of Clinical Pharmacology. vol. 85, n° 11, pp. 2524-2539, 2019-11)Article de revueLibre accès -
Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics
(Postgraduate medicine. vol. 130, n° 2, pp. 188-199, 2018-03)Article de revue -
Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database
(Pharmacoepidemiology and Drug Safety. vol. 28, n° 2, pp. 194-200, 2019)Article de revue -
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
(Pharmacoepidemiology and Drug Safety. vol. 29, n° 8, pp. 825-831, 2020)Article de revue